Chong Kun Dang Pharmaceutical Corp. (KRX: 185750)
South Korea flag South Korea · Delayed Price · Currency is KRW
96,300
+300 (0.31%)
Nov 15, 2024, 3:30 PM KST

Chong Kun Dang Pharmaceutical Company Description

Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally.

It provides prescription drugs for anticancer, anti-hypertension, anti-hyperlipidemia, anti-diabetic, and immunosuppressant products; over-the-counter drugs for therapeutic benefits, supplements, and other preventive products; health supplements with preventive benefits, including prebiotics and vitamins with Omega-3; and consumer health products, such as red-ginseng healthy drink, hand sanitizer, and hair color medication, as well as insecticides.

The company also exports its products. Chong Kun Dang Pharmaceutical Corp. was founded in 1941 and is headquartered in Seoul, South Korea.

Chong Kun Dang Pharmaceutical Corp.
Country South Korea
Founded 1941
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 2,286
CEO Young-Joo Kim

Contact Details

Address:
8, Chungjeong-ro
Seoul
South Korea
Phone 82 2 6373 0600
Website ckdpharm.com

Stock Details

Ticker Symbol 185750
Exchange Korea Stock Exchange
Fiscal Year January - December
Reporting Currency KRW
ISIN Number KR7185750007
SIC Code 2834

Key Executives

Name Position
Young-Joo Kim President, Chief Executive Officer and Chairman